Skip to main content
. 2011 May;259(2):365–374. doi: 10.1148/radiol.11100699

Table 2.

P Values for Significant Results of Pairwise Comparison of Quantitative Measures of Tumor-induced and Preexisting Vessels in Pretreatment Core Biopsy Specimens versus Posttreatment Mastectomy Specimens

graphic file with name 100699t02.jpg

Note.—Residual tumor after neoadjuvant chemotherapy = microscopic presence of residual, viable tumor cells in areas of the final resection specimen in cases of pPR. No viable tumor cells after neoadjuvant chemotherapy = microscopic absence of viable tumor cells throughout the resection specimen in cases of pCR or the microscopic absence of viable tumor cells in some areas of the resection specimen in cases of pPR. Normal breast tissue = normal tissue adjacent to the known tumor site in the mastectomy specimens.

*

CD31+CD105 = value in CD31-expressing vessels plus value in CD105-expressing vessels; CD105/CD31 = ratio of value in CD31-expressing vessels to value in CD105-expressing vessels.